Regulatory Constructs for Gerotherapeutic Drug, Biologic & Device Development: Morning Session

On May 27, 2026, the Reagan-Udall Foundation for the FDA, in collaboration with ARPA-H and XPRIZE Foundation, convened a hybrid public meeting on exploring regulatory constructs for gerotherapeutic drug, biologic and device development. Opening Remarks (5:09) The Healthspan Imperative: Geroscience, Federal and Private Sector Investment, and the Evidence Base (17:16) Landmark Evidence: What Aging Trials Have Taught Us About Endpoints, Populations, and Feasibility (46:59) Toward Regulatory Constructs: Intrinsic Capacity, Adult Health Curves, and Multi-Domain Endpoints (1:33:02)